Pharmatimes reported that Bayer HealthCare has announced a long-term strategic partnership for clinical drug development with US-based provider Covance. Bayer and Covance will work on clinical drug development, including research and development related to Phase II-IV clinical studies and central laboratory services.
Bayer Healthcare aims to better leverage Covance’s broad range of experience and services across the R&D portfolio to attain best in class operational delivery, efficiency and quality while also delivering significant financial benefits to both organizations.
John Watson, president, strategic partnering, and chief commercial officer at Covance said “We are extremely proud to have established an enduring relationship with Bayer HealthCare built on trust and proven performance that is now elevating to a strategic partnership,”
Are you searching for a new clinical job? Click here to see our latest clinical jobs
Follow us on Twitter @CKClinical to receive more industry news and CK jobs of the week updates